2 completed, 1 recruiting, 1 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Mp: new trials by email Literature Review of Mp trials Research Report on Mp
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY) (Plan 1), Fludarabine (FLU) - Fanconi Anemia, Severe Aplastic Anemia | Phase 2 | Recruiting | Masonic Cancer Center, University of Minnesota | 48 | 2018-11-13 | 2026-01-30 |
| Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia alemtuzumab, asparaginase, methotrexate - Recurrent Adult Acute Lymphoblastic Leukemia | Phase 2 | Terminated | National Cancer Institute (NCI) | 12 | 2006-06-01 | 2015-05-05 |
| Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia alemtuzumab, methotrexate, mercaptopurine - Recurrent Childhood Acute Lymphoblastic Leukemia | Phase 2 | Completed | National Cancer Institute (NCI) | 25 | 2004-07-01 | 2013-06-05 |
| Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia Anti-Thymocyte Globulin, Cyclophosphamide, Fludarabine - Fanconi Anemia | Phase 1 / Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 31 | 2000-02-17 | 2021-10-12 |
Fanconi Anemia (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Anemia, Aplastic (1) · Bone Marrow Failure Disorders (1) · Dyskeratosis Congenita (1) · Myelodysplastic Syndromes (1)
Masonic Cancer Center, University of Minnesota (2) · National Cancer Institute (NCI) (2)
United States (4)
Anne Angiolillo (1) · Margaret L. MacMillan, MD (1) · Margaret MacMillan, MD, Msc, FRCPC (1) · Peter Wiernik (1)
U01CA097452 (1), U10CA021115 (1)